LOS ANGELES, Nov. 22, 2017 /PRNewswire/ -- ImmunoCellular
Therapeutics, Ltd. ("ImmunoCellular") (NYSE American: IMUC), a
biotechnology company developing immunotherapies for the treatment
of cancer based on Stem-to-T-Cell research, announced today that
Anthony Gringeri, Ph.D., President
and Chief Executive Officer, Steven
Swanson, Ph.D., Senior Vice President, Research, and
David Fractor, Chief Financial
Officer, will present at the 10th Annual LD Micro Main
Event on Thursday, December 7, 2017
at 9:30 a.m. PT (12:30 p.m. ET) in Track 3. The conference is
being held at the Luxe Sunset Boulevard Hotel in Los Angeles, CA.
Management will be available for one-on-one meetings on
Thursday, December 7, 2017. Investors
interested in arranging a meeting with management should contact
their LD Micro representative or Lytham Partners at (602) 889-9700
or imuc@lythampartners.com.
Interested parties who wish to listen to the webcast of the
ImmunoCellular LD Micro presentation should visit the Investor
Relations section of ImmunoCellular's website at www.imuc.com,
under the Events and Presentations tab. A replay of the webcast
will be available one hour after the conclusion of the event. The
webcast will contain forward-looking statements. The information
provided on the webcast is accurate only at the time of the
webcast, and ImmunoCellular will take no responsibility for
providing updated information except as required by law.
About ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics, Ltd., based in Los Angeles, is developing immune-based
therapies for the treatment of cancer. ImmunoCellular is focused on
advancing its Stem-to-T-Cell research program, which engineers
hematopoietic stem cells to generate cytotoxic T cells. Additional
assets, for which the Company is seeking partners, include
clinical-stage programs - ICT-107, ICT-121 and ICT-140 - which are
patient-specific, dendritic cell-based immunotherapies targeting
solid tumors. To learn more about ImmunoCellular, please visit
www.imuc.com.
ImmunoCellular Therapeutics, Ltd. Contact:
Jane Green
(267) 457-3734 direct
(415) 652-4819 mobile
jane@jmgcomm.com
Investor Relations Contact:
Lytham Partners, LLC
Joe Dorame, Robert Blum, or
Joseph Diaz
(602) 889-9700
imuc@lythampartners.com
View original content with
multimedia:http://www.prnewswire.com/news-releases/immuncocellular-therapeutics-to-present-at-the-10th-annual-ld-micro-main-event-on-december-7-2017-300560205.html
SOURCE ImmunoCellular Therapeutics, Ltd.